SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- OpenAI aims to go beyond a conversational assistant with the announcement of…
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology…